𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract

✍ Scribed by Tianxiao Zhang; Rui Hua; Wei Xiao; Kathryn P. Burdon; Shomi S. Bhattacharya; Jamie E. Craig; Dandan Shang; Xiuli Zhao; David A. Mackey; Anthony T. Moore; Yang Luo; Jinsong Zhang; Xue Zhang


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
520 KB
Volume
30
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Congenital cataracts (CCs) are clinically and genetically heterogeneous. Mutations in the same gene may lead to CCs differing in inheritance, morphology and severity. Loci for autosomal dominant posterior polar CC and total CC have both been mapped to the chromosomal 1p36 region harboring the EPHA2 receptor tyrosine kinase gene. Here, we report mutations of EPHA2 in three CC families from different ancestral groups. In a Chinese family with posterior polar CC, we identified a missense mutation, c.2819C>T (p.T940I), replacing a critical amino acid that functions at the receptor oligomerization interface. In a British family with posterior polar CC and an Australian family with total CC, we found a frameshift mutation (c.2915_2916delTG) and a splicing mutation (c.2826-9G>A), respectively. These two mutations are predicted to produce novel C-terminal polypeptides with 39 identical amino acids. Yeast two-hybrid analysis showed stronger interaction between the total CC-associated mutant EPHA2 and low molecular weight protein-tyrosine phosphatase, a negative regulator of EPHA2 signaling. Our results implicate the Eph-ephrin signaling system in development of human cataract and provide a novel insight into the molecular mechanism underlying the pathogenesis of human CCs.


πŸ“œ SIMILAR VOLUMES


Novel mutations of the PCSK9 gene cause
✍ Delphine Allard; Sabine Amsellem; Marianne Abifadel; MΓ©lanie Trillard; Martine D πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 254 KB

Autosomal dominant hypercholesterolemia (ADH) is a frequent (1/500) monogenic inherited disorder characterized by isolated elevation of LDL leading to premature cardiovascular disease. ADH is known to result from mutations at two main loci: LDLR (encoding the low density lipoprotein receptor), and A

Erratum: Novel mutations of the PCSK9 ge
✍ Delphine Allard; Sabine Amsellem; Marianne Abifadel; MΓ©lanie Trillard; Martine D πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 18 KB

The original article to which this Erratum refers was published in Human Mutation 26: 497 (2005) In Table 2, the first footnote that reads "\*Associated with p.D347Y on the same allele." should read "\*Associated with p.D347Y." as it is not known if the two mutations are in cis or in trans.

Frequent mutations in the neurotrophic t
✍ Antonio Marchetti; Lara Felicioni; Giuseppe Pelosi; Maela Del Grammastro; Cateri πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 554 KB

The neurotrophic tyrosine receptor kinase (NTRK) family is potentially implicated in tumorigenesis and progression of several neoplastic diseases, including lung cancer. We investigated a large number of pulmonary neuroendocrine tumors (PNETs) and non-small cell lung carcinomas (NSCLCs) without morp

Molecular basis of congenital insensitiv
✍ Yasuhiro Indo πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 303 KB πŸ‘ 1 views

Congenital insensitivity to pain with anhidrosis (CIPA), also referred to as hereditary sensory and autonomic neuropathy type IV (HSAN-IV), is an autosomal recessive hereditary disorder characterized by recurrent episodic fever, anhidrosis (inability to sweat), absence of reaction to noxious stimuli

Two novel mutant alleles of the gene enc
✍ Marek Bodzioch; Katarzyna Lapicka; Charalampos Aslanidis; Marek Kacinski; Gerd S πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 34 KB πŸ‘ 3 views

Congenital insensitivity to pain with anhidrosis (CIPA), also called hereditary sensory and autonomic neuropathy type IV (HSAN IV), is caused by mutations of the NTRK1 gene coding for the neurotrophic tyrosine kinase receptor type 1. We report the results of the NTRK1 sequence analysis in a CIPA fam